<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Int J Infect Dis</journal-id><journal-title-group><journal-title>International Journal of Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1201-9712</issn><issn pub-type="epub">1878-3511</issn><publisher><publisher-name>The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7511210</article-id><article-id pub-id-type="pii">S1201-9712(20)32133-0</article-id><article-id pub-id-type="doi">10.1016/j.ijid.2020.09.1417</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France</article-title></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Colson</surname><given-names>Philippe</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref><xref rid="aff0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Esteves-Vieira</surname><given-names>Vera</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Giraud-Gatineau</surname><given-names>Audrey</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref><xref rid="aff0015" ref-type="aff">c</xref><xref rid="aff0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Zandotti</surname><given-names>Christine</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0025"><name><surname>Filosa</surname><given-names>V&#x000e9;ronique</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0030"><name><surname>Chaudet</surname><given-names>Herv&#x000e9;</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref><xref rid="aff0015" ref-type="aff">c</xref><xref rid="aff0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="aut0035"><name><surname>Lagier</surname><given-names>Jean-Christophe</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref><xref rid="aff0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="aut0040"><name><surname>Raoult</surname><given-names>Didier</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref><xref rid="aff0015" ref-type="aff">c</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><aff id="aff0005"><label>a</label>IHU M&#x000e9;diterran&#x000e9;e Infection, Marseille, France</aff><aff id="aff0010"><label>b</label>Assistance Publique-H&#x000f4;pitaux de Marseille (AP-HM), Marseille, France</aff><aff id="aff0015"><label>c</label>Aix-Marseille Univ., Microbes Evolution Phylogeny and Infections (MEPHI), Institut de recherche pour le d&#x000e9;veloppement (IRD), Marseille, France</aff><aff id="aff0020"><label>d</label>Service de Sant&#x000e9; des Arm&#x000e9;es (SSA), Marseille, France</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding author at: IHU - M&#x000e9;diterran&#x000e9;e Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.</corresp></author-notes><pub-date pub-type="pmc-release"><day>23</day><month>9</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>12</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>9</month><year>2020</year></pub-date><volume>101</volume><fpage>121</fpage><lpage>125</lpage><history><date date-type="received"><day>7</day><month>8</month><year>2020</year></date><date date-type="rev-recd"><day>11</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>15</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Authors</copyright-statement><copyright-year>2020</copyright-year><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract abstract-type="author-highlights" id="abs0005"><title>Highlights</title><p><list list-type="simple" id="lis0005"><list-item id="lsti0005"><label>&#x02022;</label><p id="par0005">Comparable bell-shaped distributions for SARS-CoV-2 and endemic coronaviruses.</p></list-item><list-item id="lsti0010"><label>&#x02022;</label><p id="par0010">Different age distributions for SARS-CoV-2 and other respiratory viruses.</p></list-item><list-item id="lsti0015"><label>&#x02022;</label><p id="par0015">Fewer children among all SARS-CoV-2-positive than all endemic coronavirus-positive.</p></list-item><list-item id="lsti0020"><label>&#x02022;</label><p id="par0020">SARS-CoV-2 was the only respiratory virus to spare children.</p></list-item></list></p></abstract><abstract id="abs0010"><sec><title>Objectives</title><p>The SARS-CoV-2 epidemic presents a poorly understood epidemiological cycle. We aimed to compare the age and weekly distributions of the five human coronaviruses, including SARS-CoV-2, that circulated in southeastern France.</p></sec><sec><title>Methods</title><p>We analyzed all available diagnoses of respiratory viruses, including SARS-CoV-2, performed between 09/2013 and 05/2020 at the University Hospital Institute M&#x000e9;diterran&#x000e9;e Infection in Marseille, southeastern France.</p></sec><sec><title>Results</title><p>For SARS-CoV-2, positive children &#x0003c;15 years of age represented 3.4% (228/6,735) of all positive cases, which is significantly less than for endemic coronaviruses (46.1%; 533/1,156; p&#x02009;&#x0003c;&#x02009;0.001). Among 10,026 patients tested for SARS-CoV-2 and endemic coronaviruses in 2020, children &#x0003c;15 years represented a significantly lower proportion of all positive cases for SARS-CoV-2 than for endemic coronaviruses [2.2% (24/1,067) vs. 33.5% (149/445), respectively; p&#x02009;&#x0003c;&#x02009;0.001]. Epidemic curves for endemic coronaviruses and SARS-CoV-2 in 91,722 patients showed comparable bell-shaped distributions with a slight time lag. In contrast, the age distribution of endemic coronaviruses and 14 other respiratory viruses differed significantly compared to that of SARS-CoV-2, which was the only virus to relatively spare children.</p></sec><sec><title>Conclusions</title><p>We observed for SARS-CoV-2 a temporal distribution resembling that of endemic coronaviruses but an age distribution that relatively spares the youngest subjects, who are those the most exposed to endemic coronaviruses.</p></sec></abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>SARS-CoV-2</kwd><kwd>Endemic coronavirus</kwd><kwd>Age</kwd><kwd>Children</kwd><kwd>Cross-immunity</kwd><kwd>Southeastern France</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><title>Introduction</title><p id="par0025">The SARS-CoV-2 epidemic, which apparently started in December 2019 in China (<xref rid="bib0055" ref-type="bibr">Wu and McGoogan, 2020</xref>), currently presents a poorly understood epidemiological cycle. In China, Korea, and now in Europe, it seems to have had a bell-shaped distribution (<ext-link ext-link-type="uri" xlink:href="https://coronavirus.jhu.edu/data/new-cases" id="intr0005">https://coronavirus.jhu.edu/data/new-cases</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.mediterranee-infection.com/covid-19/" id="intr0010">https://www.mediterranee-infection.com/covid-19/</ext-link>) as is typical for viral respiratory infections. Furthermore, we and others have shown that detection of SARS-CoV-2 in children is rare, as are clinical cases (<xref rid="bib0010" ref-type="bibr">Colson et al., 2020</xref>, <xref rid="bib0025" ref-type="bibr">Gudbjartsson et al., 2020</xref>, <xref rid="bib0035" ref-type="bibr">Jones et al., 2020</xref>, <xref rid="bib0040" ref-type="bibr">Li et al., 2020</xref>, <xref rid="bib0055" ref-type="bibr">Wu and McGoogan, 2020</xref>). In three extensive studies, children under ten years of age accounted for &#x0003c;1%, 0%, and 1.3% of SARS-CoV-2 cases in China (<xref rid="bib0055" ref-type="bibr">Wu and McGoogan, 2020</xref>), Iceland (<xref rid="bib0025" ref-type="bibr">Gudbjartsson et al., 2020</xref>), and Germany (<xref rid="bib0035" ref-type="bibr">Jones et al., 2020</xref>), respectively. The fate of this epidemic remains unknown, but we found it interesting to compare the age and weekly distribution of the five human coronaviruses, including SARS-CoV-2, that circulated in southeastern France in order to compare the temporal and age distribution of these different viruses.</p></sec><sec id="sec0010"><title>Methods</title><p id="par0030">We analyzed all available diagnoses of respiratory viruses, including SARS-CoV-2, performed between September 2013 and May 2020 at the clinical microbiology and virology laboratory of the University Hospital Institute M&#x000e9;diterran&#x000e9;e Infection (<ext-link ext-link-type="uri" xlink:href="https://www.mediterranee-infection.com/" id="intr0015">https://www.mediterranee-infection.com/</ext-link>) and the University Hospitals of Marseille, the second-largest French city, southeastern France. Testing of respiratory samples was performed using the FTD Respiratory pathogens 21 (Fast Track Diagnosis, Luxembourg), the Biofire FilmArray Respiratory panel 2 plus (Biom&#x000e9;rieux, Marcy-l'Etoile, France), the Respiratory Multi-Well System r-gene (Argene, BioM&#x000e9;rieux), or the GeneXpert Xpert Flu/RSV (Cepheid, Sunnyvale, CA) assays, or by one-step simplex real-time quantitative RT-PCR amplifications as previously reported (<xref rid="bib0030" ref-type="bibr">Hoang et al., 2019</xref>). Diagnosis by reverse transcription-PCR of SARS-CoV-2 infection was performed as previously described (<xref rid="bib0005" ref-type="bibr">Amrane et al., 2020</xref>). This study retrospectively analyzed patients' data from the hospital information system (RGPD/APHM 2019-73). Statistics were performed using OpenEpi version 3.01 software (<ext-link ext-link-type="uri" xlink:href="https://www.openepi.com/Menu/OE_Menu.htm" id="intr0020">https://www.openepi.com/Menu/OE_Menu.htm</ext-link>); a p-value&#x02009;&#x0003c;&#x02009;0.05 was considered significant. Moreover, epidemic curves were analyzed by Markov Chain Monte Carlo fitting of five commonly used distributions with different skewnesses (Normal, Log-normal, Gamma, Weibull, Gompertz) using R-4.0.1 (<ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/" id="intr0025">https://www.r-project.org/</ext-link>). Distributions with the best goodness-of-fit criteria [Akaike's Information Criterion, (AIC)] were chosen, and their parameters bootstrapped.</p></sec><sec id="sec0015"><title>Results</title><p id="par0035">First, we analyzed all available diagnoses of SARS-CoV-2 and other respiratory viruses for 141,227 patients. Between January and May 2020, we tested respiratory samples from 80,024 patients for SARS-CoV-2 and found 6,735 (8.4%) positive (<xref rid="fig0005" ref-type="fig">Figure 1</xref>
). In addition, between September 2013 and May 2020, we tested respiratory samples from 69,752 patients for respiratory viruses. Of these, 17,673 were tested for endemic coronaviruses (HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1) and 1,156 (6.5%) were positive. For SARS-CoV-2, positive children under 15 years represented 3.4% (228/6,735) of all positive patients. This proportion was significantly lower than that for endemic coronaviruses (46.1%; 533/1,156; p&#x02009;&#x0003c;&#x02009;0.001, Chi&#x02013;square test). In fact, positive patients in each group 0&#x02212;1 year, 1&#x02212;5 years, 5&#x02212;10 years, and 10&#x02212;15 years represented significantly lower proportions of all positive patients when comparing SARS-CoV-2 to other endemic coronavirus infections (<xref rid="tbl0005" ref-type="table">Table 1</xref>
). Compared to SARS-CoV-2-positive patients, those infected with endemic coronaviruses or other respiratory viruses were significantly more likely to be &#x0003c;10 years of age (<xref rid="fig0005" ref-type="fig">Figure 1</xref>). Therefore, this age group accounted for 1.8% of SARS-CoV-2 cases compared to between 25.0% (for HCoV-229E) and 87.0% (for bocavirus) of infections with other respiratory viruses (p&#x02009;&#x0003c;&#x02009;0.05 for all comparisons).<fig id="fig0005"><label>Figure 1</label><caption><p>Age distribution of the proportions of patients diagnosed with coronaviruses and other respiratory viruses compared to the total population tested.</p><p>(i) SARS-CoV-2; (ii) Coronavirus-229E; (iii) Coronavirus-NL63; (iv) Coronavirus-OC43; (v) Coronavirus-HKU1; (vi) Metapneumovirus; (vii) Rhinovirus; (viii) Enterovirus; (ix) Paraechovirus; (x) Adenovirus; (xi) Influenza A H3N2 virus; (xii) Influenza A H1N1 virus; (xiii) Influenza B virus; (xiv) Respiratory syncytial virus; (xv) Bocavirus; (xvi) Human parainfluenzavirus 1; (xvii) Human parainfluenzavirus 2; (xviii) Human parainfluenzavirus 3; (xix) Human parainfluenzavirus 4.</p></caption><alt-text id="at0005">Figure 1</alt-text><graphic xlink:href="gr1_lrg"/></fig><table-wrap position="float" id="tbl0005"><label>Table 1</label><caption><p>Number of cases per age group for all patients tested for SARS-CoV-2 or for endemic coronaviruses, and proportion of all tested patients per age group.</p></caption><alt-text id="at0015">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Age group</th><th colspan="4" align="left">SARS-CoV-2<hr/></th><th colspan="4" align="left">Endemic CoV<hr/></th><th align="left">P<xref rid="tblfn0005" ref-type="table-fn">*</xref></th></tr><tr><th align="left">(years)</th><th colspan="2" align="left">Tested<hr/></th><th colspan="2" align="left">Positive<hr/></th><th colspan="2" align="left">Tested<hr/></th><th colspan="2" align="left">Positive<hr/></th><th align="left"/></tr><tr><th align="left"/><th align="left">N</th><th align="left"><italic>%</italic><xref rid="tblfn0010" ref-type="table-fn">**</xref></th><th align="left">N</th><th align="left"><italic>%</italic><xref rid="tblfn0010" ref-type="table-fn">**</xref></th><th align="left">N</th><th align="left"><italic>%</italic><xref rid="tblfn0010" ref-type="table-fn">**</xref></th><th align="left">N</th><th align="left"><italic>%</italic><xref rid="tblfn0010" ref-type="table-fn">**</xref></th><th align="left"/></tr></thead><tbody><tr><td align="left">0&#x02212;1</td><td align="left">796</td><td align="left"><italic>1.0</italic></td><td align="left">32</td><td align="left"><italic>0.5</italic></td><td align="left">2 412</td><td align="left"><italic>14.6</italic></td><td align="left">207</td><td align="left"><italic>17.9</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">1&#x02212;5</td><td align="left">1 453</td><td align="left"><italic>1.8</italic></td><td align="left">40</td><td align="left"><italic>0.6</italic></td><td align="left">1 661</td><td align="left"><italic>11.3</italic></td><td align="left">217</td><td align="left"><italic>18.8</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">5&#x02212;10</td><td align="left">1 231</td><td align="left"><italic>1.5</italic></td><td align="left">50</td><td align="left"><italic>0.7</italic></td><td align="left">628</td><td align="left"><italic>4.9</italic></td><td align="left">65</td><td align="left"><italic>5.6</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">10&#x02212;15</td><td align="left">1 197</td><td align="left"><italic>1.5</italic></td><td align="left">106</td><td align="left"><italic>1.6</italic></td><td align="left">366</td><td align="left"><italic>3.0</italic></td><td align="left">44</td><td align="left"><italic>3.8</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">15&#x02212;18</td><td align="left">1 090</td><td align="left"><italic>1.4</italic></td><td align="left">118</td><td align="left"><italic>1.8</italic></td><td align="left">202</td><td align="left"><italic>1.6</italic></td><td align="left">12</td><td align="left"><italic>1</italic></td><td align="left">0.051</td></tr><tr><td align="left">18&#x02212;25</td><td align="left">6 680</td><td align="left"><italic>8.3</italic></td><td align="left">594</td><td align="left"><italic>8.8</italic></td><td align="left">409</td><td align="left"><italic>3.9</italic></td><td align="left">43</td><td align="left"><italic>3.7</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">25&#x02212;45</td><td align="left">27 059</td><td align="left"><italic>33.6</italic></td><td align="left">2 184</td><td align="left"><italic>32.4</italic></td><td align="left">1 502</td><td align="left"><italic>14.9</italic></td><td align="left">165</td><td align="left"><italic>14.3</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">45&#x02212;65</td><td align="left">24 487</td><td align="left"><italic>30.4</italic></td><td align="left">2 257</td><td align="left"><italic>33.5</italic></td><td align="left">2 250</td><td align="left"><italic>18.3</italic></td><td align="left">176</td><td align="left"><italic>15.2</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">65&#x02212;75</td><td align="left">6 545</td><td align="left"><italic>8.1</italic></td><td align="left">560</td><td align="left"><italic>8.3</italic></td><td align="left">1 419</td><td align="left"><italic>10.3</italic></td><td align="left">79</td><td align="left"><italic>6.8</italic></td><td align="left">0.050</td></tr><tr><td align="left">&#x0003e;75</td><td align="left">9 986</td><td align="left"><italic>12.4</italic></td><td align="left">794</td><td align="left"><italic>11.8</italic></td><td align="left">2 528</td><td align="left"><italic>17.2</italic></td><td align="left">148</td><td align="left"><italic>12.8</italic></td><td align="left">0.175</td></tr><tr><td align="left">Total</td><td align="left">80 524</td><td align="left"><italic>100.0</italic></td><td align="left">6 735</td><td align="left"><italic>100.0</italic></td><td align="left">17 673</td><td align="left"><italic>100.0</italic></td><td align="left">1 156</td><td align="left"><italic>100.0</italic></td><td align="left">&#x02013;</td></tr></tbody></table><table-wrap-foot><fn id="tblfn0005"><label>*</label><p id="npar0005">Yates-corrected Chi&#x02013;square test.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn0010"><label>**</label><p id="npar0010">Proportion of cases in the age group compared to the total number of cases.</p></fn></table-wrap-foot></table-wrap></p><p id="par0040">Second, we analyzed 10,026 patients who were tested for both SARS-CoV-2 and endemic coronaviruses between January 1st and May 25th, 2020. A total of 1,067 patients (10.6%) were SARS-CoV-2- positive, and 445 (4.4%) were diagnosed with endemic coronaviruses. Children under 15 years of age accounted for a significantly lower proportion of all positive cases for SARS-CoV-2 than for endemic coronaviruses [2.2% (24/1,067) vs. 33.5% (149/445), respectively; p&#x02009;&#x0003c;&#x02009;0.001] as was the case in each age group: 0&#x02212;1 year, 1&#x02212;5 years, 5&#x02212;10 years and 10&#x02212;15 years (<xref rid="fig0005" ref-type="fig">Figure 1</xref>i&#x02013;v, <xref rid="tbl0010" ref-type="table">Table 2</xref>
). Only eleven (0.11%) patients were infected with SARS-CoV-2 and an endemic coronavirus. They represented a significantly lower proportion than the proportion of SARS-CoV-2-positive patients among those negative for endemic coronaviruses [11/445 (2.5%) vs 1,056/9,581 (11.0%); p&#x02009;&#x0003c;&#x02009;0.001]. None of these eleven patients was under 18 years of age.<table-wrap position="float" id="tbl0010"><label>Table 2</label><caption><p>Number of cases per age group for SARS-CoV-2 or endemic coronaviruses for patients tested for all five coronaviruses, and proportion of all tested patients per age group.</p></caption><alt-text id="at0020">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Age group (years)</th><th colspan="2" align="left">Tested<hr/></th><th colspan="2" align="left">SARS-CoV-2-positive<hr/></th><th colspan="2" align="left">Endemic CoV-positive<hr/></th><th align="left">P<xref rid="tblfn0015" ref-type="table-fn">*</xref></th></tr><tr><th align="left"/><th align="left">N</th><th align="left"><italic>%</italic><xref rid="tblfn0025" ref-type="table-fn">***</xref></th><th align="left">N</th><th align="left"><italic>%</italic><xref rid="tblfn0025" ref-type="table-fn">***</xref></th><th align="left">N</th><th align="left"><italic>%</italic><xref rid="tblfn0025" ref-type="table-fn">***</xref></th><th align="left"/></tr></thead><tbody><tr><td align="left">0&#x02212;1</td><td align="left">477</td><td align="left"><italic>4,8</italic></td><td align="left">11</td><td align="left"><italic>1.0</italic></td><td align="left">41</td><td align="left"><italic>9.2</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">1&#x02212;5</td><td align="left">715</td><td align="left"><italic>7,1</italic></td><td align="left">5</td><td align="left"><italic>0.5</italic></td><td align="left">68</td><td align="left"><italic>15.3</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">5&#x02212;10</td><td align="left">402</td><td align="left"><italic>4,0</italic></td><td align="left">4</td><td align="left"><italic>0.4</italic></td><td align="left">18</td><td align="left"><italic>4.0</italic></td><td align="left">&#x0003c;0.001<xref rid="tblfn0020" ref-type="table-fn">**</xref></td></tr><tr><td align="left">10&#x02212;15</td><td align="left">270</td><td align="left"><italic>2,7</italic></td><td align="left">4</td><td align="left"><italic>0.4</italic></td><td align="left">22</td><td align="left"><italic>4.9</italic></td><td align="left">&#x0003c;0.001<xref rid="tblfn0020" ref-type="table-fn">**</xref></td></tr><tr><td align="left">15&#x02212;18</td><td align="left">160</td><td align="left"><italic>1,6</italic></td><td align="left">11</td><td align="left"><italic>1.0</italic></td><td align="left">5</td><td align="left"><italic>1.1</italic></td><td align="left">0.454</td></tr><tr><td align="left">18&#x02212;25</td><td align="left">590</td><td align="left"><italic>5,9</italic></td><td align="left">75</td><td align="left"><italic>7.0</italic></td><td align="left">25</td><td align="left"><italic>5.6</italic></td><td align="left">0.186</td></tr><tr><td align="left">25&#x02212;45</td><td align="left">2321</td><td align="left">23,1</td><td align="left">245</td><td align="left"><italic>23.0</italic></td><td align="left">109</td><td align="left"><italic>24.5</italic></td><td align="left">0.283</td></tr><tr><td align="left">45&#x02212;65</td><td align="left">2491</td><td align="left">24,8</td><td align="left">385</td><td align="left"><italic>36.1</italic></td><td align="left">83</td><td align="left"><italic>18.7</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">65&#x02212;75</td><td align="left">1002</td><td align="left">10,0</td><td align="left">128</td><td align="left"><italic>12.0</italic></td><td align="left">26</td><td align="left"><italic>5.8</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">&#x0003e;75</td><td align="left">1598</td><td align="left">15,9</td><td align="left">199</td><td align="left"><italic>18.7</italic></td><td align="left">48</td><td align="left"><italic>10.8</italic></td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">Total</td><td align="left">10026</td><td align="left">100,0</td><td align="left">1067</td><td align="left"><italic>100.0</italic></td><td align="left">445</td><td align="left"><italic>100.0</italic></td><td align="left">&#x02013;</td></tr></tbody></table><table-wrap-foot><fn id="tblfn0015"><label>*</label><p id="npar0015">Yates-corrected Chi&#x02013;square test.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn0020"><label>**</label><p id="npar0020">Fischer exact test.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn0025"><label>***</label><p id="npar0025">Proportion of cases in the age group compared to the total number of cases.</p></fn></table-wrap-foot></table-wrap></p><p id="par0045">Moreover, over one year (from June 2019 to May 2020), we observed that epidemic curves were comparable for the four endemic coronaviruses and SARS-CoV-2 (<xref rid="fig0010" ref-type="fig">Figure 2</xref>B). Cases of endemic coronavirus increased in December 2019, peaked in mid-March 2020, and ended in early April, while cases of SARS-CoV-2 increased in early March, peaked in late March, and nearly ended in mid-May. The fitted distributions reflected three kinds of epidemic curves (Supplementary Figure 1). SARS-CoV-2 fitted with a left-skewed Gamma distribution (AIC&#x02009;=&#x02009;26345.6). HCoV-OC43 fitted with a quasi-symmetric curve and Normal distribution (AIC&#x02009;=&#x02009;971.4). Epidemic curves of HCoV-229E, HCoV-NL63, and HCoV-HKU1 were right-skewed and fitted with a Gompertz distribution (AIC&#x02009;=&#x02009;394.5, 1191.2, and 1861.2, respectively).<fig id="fig0010"><label>Figure 2</label><caption><p>Number of patients positive for coronaviruses over one year from June 2019 through May 2020.</p><p>(i) SARS-CoV-2; (ii) HCoV-229E; (iii) HCoV-NL63; (iv) HCoV-OC43; (v) HCoV-HKU1.</p><p>The X-axis corresponds to weeks and years (week-year).</p></caption><alt-text id="at0010">Figure 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p></sec><sec id="sec0020"><title>Discussion</title><p id="par0050">In this large study, two elements are particularly noteworthy. First, in our geographical area the temporal distributions of infections by all coronaviruses are comparable. Thus, all five viruses exhibit a bell-shaped incidence curve, and their circulation stopped in the spring, suggesting that this is the natural SARS-CoV-2 epidemic pattern. Hence, we can speculate for temperate countries, including Europe, that SARS-CoV-2 could reappear seasonally during winter and circulate epidemically until spring. Alternatively, SARS-CoV-2 might disappear in the absence of an asymptomatic human chronic carriage, like SARS-CoV-1 (<xref rid="bib0050" ref-type="bibr">Raoult et al., 2020</xref>). Second, the age distribution of SARS-CoV-2 cases largely spares children, which is radically different from other coronavirus and respiratory virus infections. Thus, SARS-CoV-2 is the only one we analyzed that does not significantly affect children. Therefore, its epidemiology cannot be predicted based on previous knowledge of viral respiratory diseases. The simplest explanation for this difference is that a substantial proportion of children, particularly those under five years of age, may have acquired immunity to endemic coronaviruses that infect young children with high frequencies (<xref rid="bib0050" ref-type="bibr">Raoult et al., 2020</xref>, <xref rid="bib0060" ref-type="bibr">Zhou et al., 2013</xref>). Indeed, there is evidence that part of the population exhibited immune responses against SARS-CoV-2 before the epidemic, supporting the hypothesis of cross-immunity between endemic coronaviruses and the new coronavirus. Thus, in the US, circulating SARS-CoV-2-specific CD4+ and CD8+ T cells were detected in &#x02248;20&#x02212;60% of unexposed individuals sampled in 2015&#x02013;2018 (<xref rid="bib0020" ref-type="bibr">Grifoni et al., 2020</xref>). In the UK, IgG to SARS-CoV-2 were detected in 15% of SARS-CoV-2-uninfected patients with recent HCoV infection and in 10% of SARS-CoV-2-uninfected pregnant women (<xref rid="bib0045" ref-type="bibr">Ng et al., 2020</xref>). Also, we detected IgM to SARS-CoV-2 at titers &#x02265;1:100 in 9/50 patients with endemic coronaviruses (<xref rid="bib0015" ref-type="bibr">Edouard et al., 2020</xref>). It is also worth noting that the coinfection rate observed here with SARS-CoV-2 and another coronavirus was very low (0.1%) and that SARS-CoV-2-positivity was significantly lower among patients positive than negative for an endemic coronavirus, which supports the hypothesis of a protective cross-immunity.</p><p id="par0055">Overall, we believe that this work contributes to the understanding of the epidemiology of SARS-CoV-2, which has a temporal distribution resembling that of endemic coronaviruses but an age distribution that largely spares the youngest subjects, who are precisely those the most frequently exposed to endemic coronaviruses and may have consequently acquired protective immunity. Susceptibility to SARS-CoV-2 in the elderly perhaps reflects the loss of immunity acquired during childhood or changes in social organization that occurred during recent decades. Indeed, a small proportion of people over the age of 50 lived in communities with very young children, whereas women&#x02019;s work evolution has led to much earlier socialization of children. Finally, the fact that age distributions for infections by SARS-CoV-2 and other respiratory viruses differ, underscores that real data collection and real-time analysis are critical in the event of an outbreak to decipher the epidemiology of emerging pathogens.</p></sec><sec id="sec0025"><title>Ethics</title><p id="par0060">All data have been generated as part of the routine work at Assistance Publique-H&#x000f4;pitaux de Marseille (Marseille university hospitals), and this study results from routine standard clinical management. Access to the patients&#x02019; biological and registry data from the hospital information system was approved by the data protection committee of Assistance Publique-H&#x000f4;pitaux de Marseille (APHM). It was recorded in the European General Data Protection Regulation registry under number RGPD/APHM 2019-73. This study has been approved by our institution&#x02019;s ethics committee (N&#x000b0;: 2020-029). The authors have no conflicts of interest to declare. Funding sources had no role in the study's design and conduct, collection, management, analysis and interpretation of the data, and preparation, review, or approval of the manuscript.</p></sec><sec id="sec0030"><title>Conflict of interest</title><p id="par0065">None declared.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Amrane</surname><given-names>S.</given-names></name><name><surname>Tissot-Dupont</surname><given-names>H.</given-names></name><name><surname>Doudier</surname><given-names>B.</given-names></name><name><surname>Eldin</surname><given-names>C.</given-names></name><name><surname>Hocquart</surname><given-names>M.</given-names></name><name><surname>Mailhe</surname><given-names>M.</given-names></name></person-group><article-title>Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, -January 31st to March 1st, 2020: a respiratory virus snapshot</article-title><source>Travel Med Infect Dis</source><year>2020</year><fpage>101632</fpage><pub-id pub-id-type="pmid">32205269</pub-id></element-citation></ref><ref id="bib0010"><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>Tissot-Dupont</surname><given-names>H.</given-names></name><name><surname>Morand</surname><given-names>A.</given-names></name><name><surname>Boschi</surname><given-names>C.</given-names></name><name><surname>Ninove</surname><given-names>L.</given-names></name><name><surname>Esteves-Vieira</surname><given-names>V.</given-names></name></person-group><article-title>Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults</article-title><source>Eur J Infect Dis Clin Microbiol</source><volume>39</volume><year>2020</year><fpage>1983</fpage><lpage>1987</lpage></element-citation></ref><ref id="bib0015"><element-citation publication-type="book" id="sbref0015"><person-group person-group-type="author"><name><surname>Edouard</surname><given-names>S.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>Melenotte</surname><given-names>C.</given-names></name><name><surname>De Pinto</surname><given-names>F.</given-names></name><name><surname>Thomas</surname><given-names>L.</given-names></name><name><surname>La Scola</surname><given-names>B.</given-names></name></person-group><chapter-title>Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France</chapter-title><comment>URL:</comment><year>2020</year><publisher-name>Preprint MedRxiv</publisher-name><pub-id pub-id-type="doi">10.1101/2020.05.05.20092064</pub-id></element-citation></ref><ref id="bib0020"><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Grifoni</surname><given-names>A.</given-names></name><name><surname>Weiskopf</surname><given-names>D.</given-names></name><name><surname>Ramirez</surname><given-names>S.I.</given-names></name><name><surname>Mateus</surname><given-names>J.</given-names></name><name><surname>Dan</surname><given-names>J.M.</given-names></name><name><surname>Moderbacher</surname><given-names>C.R.</given-names></name></person-group><article-title>Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals</article-title><source>Cell</source><volume>181</volume><year>2020</year><fpage>1489</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.05.015</pub-id><comment>S0092-8674(20)30610-30613</comment><pub-id pub-id-type="pmid">32473127</pub-id></element-citation></ref><ref id="bib0025"><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Gudbjartsson</surname><given-names>D.F.</given-names></name><name><surname>Helgason</surname><given-names>A.</given-names></name><name><surname>Jonsson</surname><given-names>H.</given-names></name><name><surname>Magnusson</surname><given-names>O.T.</given-names></name><name><surname>Melsted</surname><given-names>P.</given-names></name><name><surname>Norddahl</surname><given-names>G.L.</given-names></name></person-group><article-title>Spread of SARS-CoV-2 in the icelandic population</article-title><source>N Engl J Med</source><volume>382</volume><year>2020</year><fpage>2302</fpage><lpage>2315</lpage><pub-id pub-id-type="pmid">32289214</pub-id></element-citation></ref><ref id="bib0030"><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>V.T.</given-names></name><name><surname>Goumballa</surname><given-names>N.</given-names></name><name><surname>Dao</surname><given-names>T.L.</given-names></name><name><surname>Ly</surname><given-names>T.D.A.</given-names></name><name><surname>Ninove</surname><given-names>L.</given-names></name><name><surname>Ranque</surname><given-names>S.</given-names></name></person-group><article-title>Respiratory and gastrointestinal infections at the 2017 Grand Magal de Touba, Senegal: a prospective cohort survey</article-title><source>Travel Med Infect Dis</source><volume>32</volume><year>2019</year><fpage>101410</fpage></element-citation></ref><ref id="bib0035"><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>Tc</given-names></name><name><surname>Muhlemann</surname><given-names>B.</given-names></name><name><surname>Veith</surname><given-names>T.</given-names></name><name><surname>Zuchowski</surname><given-names>M.</given-names></name><name><surname>Hofman</surname><given-names>J.</given-names></name><name><surname>Stein</surname><given-names>A.</given-names></name></person-group><article-title>An analysis of SARS-CoV-2 viral load by patient age</article-title><source>medRxiv preprint</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.06.08.20125484</pub-id></element-citation></ref><ref id="bib0040"><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Dozier</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Kirolos</surname><given-names>A.</given-names></name><name><surname>Theodoratou</surname><given-names>E.</given-names></name></person-group><article-title>The role of children in transmission of SARS-CoV-2: a rapid review</article-title><source>J Glob Health</source><volume>10</volume><year>2020</year><fpage>011101</fpage><pub-id pub-id-type="pmid">32612817</pub-id></element-citation></ref><ref id="bib0045"><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>K.</given-names></name><name><surname>Faulkner</surname><given-names>N.</given-names></name><name><surname>Cornish</surname><given-names>G.</given-names></name><name><surname>Rosa</surname><given-names>A.</given-names></name><name><surname>Earl</surname><given-names>C.</given-names></name><name><surname>Wrobel</surname><given-names>A.</given-names></name></person-group><article-title>Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans</article-title><source>bioRxiv preprint</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.05.14.095414</pub-id></element-citation></ref><ref id="bib0050"><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Raoult</surname><given-names>D.</given-names></name><name><surname>Zumla</surname><given-names>A.</given-names></name><name><surname>Locatelli</surname><given-names>F.</given-names></name><name><surname>Ippolito</surname><given-names>G.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group><article-title>Coronavirus infections: epidemiological, clinical and immunological features and hypotheses</article-title><source>Cell Stress</source><volume>4</volume><year>2020</year><fpage>66</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">32292881</pub-id></element-citation></ref><ref id="bib0055"><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>McGoogan</surname><given-names>J.M.</given-names></name></person-group><article-title>Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention</article-title><source>JAMA</source><year>2020</year><fpage>2762130</fpage></element-citation></ref><ref id="bib0060"><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>R.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name></person-group><article-title>First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood</article-title><source>BMC Infect Dis</source><volume>13</volume><year>2013</year><fpage>433</fpage><pub-id pub-id-type="pmid">24040960</pub-id></element-citation></ref></ref-list><sec id="sec0040" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="par0080">The following are Supplementary data to this article:<supplementary-material content-type="local-data" id="upi0005"><media xlink:href="mmc1.docx"/></supplementary-material>
<fig id="upi0010" position="anchor"><graphic xlink:href="mmc2_lrg"/></fig>
<fig id="upi0015" position="anchor"><graphic xlink:href="mmc3_lrg"/></fig>
</p></sec><ack id="ack0005"><title>Acknowledgments</title><p id="par0070">This work was supported by the French Government under the &#x0201c;Investments for the Future&#x0201d; program managed by the <funding-source id="gs0005">National Agency for Research (ANR)</funding-source>, M&#x000e9;diterran&#x000e9;e-Infection 10-IAHU-03 and was also supported by R&#x000e9;gion Provence Alpes C&#x000f4;te d&#x02019;Azur and European funding <funding-source id="gs0010"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100008530</institution-id><institution>FEDER</institution></institution-wrap></funding-source>
<funding-source id="gs0015">PRIMMI</funding-source> (Fonds Europ&#x000e9;en de D&#x000e9;veloppement R&#x000e9;gional-Plateformes de Recherche et d'Innovation Mutualis&#x000e9;es M&#x000e9;diterran&#x000e9;e Infection), FEDER PA 0000320 PRIMMI. We are very grateful to Laurence Thomas, Elsa Prudent and C&#x000e9;line Gazin for their technical help.</p></ack><fn-group><fn id="sec0035" fn-type="supplementary-material"><label>Appendix A</label><p id="par0075">Supplementary material related to this article can be found, in the online version, at doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijid.2020.09.1417" id="intr0030">https://doi.org/10.1016/j.ijid.2020.09.1417</ext-link>.</p></fn></fn-group></back></article>